Literature DB >> 21996643

Unraveling the association between SSRI use and falls: an experimental study of risk factors for accidental falls in long-term paroxetine users.

Judith Hegeman1, Bart van den Bemt, Vivian Weerdesteyn, Bart Nienhuis, Jacques van Limbeek, Jacques Duysens.   

Abstract

Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat depression and are also associated with an increased falls risk. However, the biological mechanism underlying accidental falls with SSRI intake has yet to be elucidated. The present experimental study was designed to investigate whether obstacle avoidance skills in long-term (>90 days), senior paroxetine users (61 ± 5.8 years) are affected during gait, simple and challenging postural balance tasks, as well as during manual reaction time tasks. The performance of the paroxetine users was compared with healthy group-matched controls (60 ± 4.8 years). The results demonstrated impaired postural balance in the paroxetine users, especially during one-legged stance or under various dual-task conditions. Although the deficit in one-legged stance could indicate vestibular involvement, this was deemed unlikely because performance of standing on compliant surface with closed eyes remained unaffected. Paroxetine use also failed to affect manual reaction times or obstacle avoidance performance. It is suggested that paroxetine affects attentional capacities particularly in conjunction with balance control. Compared with healthy seniors, long-term senior users of paroxetine seem to be at an increased risk of falling due to impairments in balance control, especially when attention has to be divided between 2 concurrent activities.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21996643     DOI: 10.1097/WNF.0b013e31823337d1

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  6 in total

1.  Factors associated with falls in older adults with cancer: a validated model from the Cancer and Aging Research Group.

Authors:  Tanya M Wildes; Ronald J Maggiore; William P Tew; David Smith; Can-Lan Sun; Harvey Cohen; Supriya G Mohile; Ajeet Gajra; Heidi D Klepin; Cynthia Owusu; Cary P Gross; Hyman Muss; Andrew Chapman; Stuart M Lichtman; Vani Katheria; Arti Hurria
Journal:  Support Care Cancer       Date:  2018-04-28       Impact factor: 3.603

Review 2.  Cause or Effect? Selective Serotonin Reuptake Inhibitors and Falls in Older Adults: A Systematic Review.

Authors:  Marie Anne Gebara; Kim L Lipsey; Jordan F Karp; Maureen C Nash; Andrea Iaboni; Eric J Lenze
Journal:  Am J Geriatr Psychiatry       Date:  2014-11-25       Impact factor: 4.105

Review 3.  Pharmacological treatment in Parkinson's disease: Effects on gait.

Authors:  Katrijn Smulders; Marian L Dale; Patricia Carlson-Kuhta; John G Nutt; Fay B Horak
Journal:  Parkinsonism Relat Disord       Date:  2016-07-17       Impact factor: 4.891

4.  Is it possible to identify risks for injurious falls in hospitalized patients?

Authors:  Lorraine C Mion; A Michelle Chandler; Teresa M Waters; Mary S Dietrich; Lori A Kessler; Stephen T Miller; Ronald I Shorr
Journal:  Jt Comm J Qual Patient Saf       Date:  2012-09

5.  Psychiatric disorders, psychotropic medication use and falls among women: an observational study.

Authors:  Lana J Williams; Julie A Pasco; Amanda L Stuart; Felice N Jacka; Sharon L Brennan; Amelia G Dobbins; Risto Honkanen; Heli Koivumaa-Honkanen; Päivi H Rauma; Michael Berk
Journal:  BMC Psychiatry       Date:  2015-04-08       Impact factor: 3.630

6.  The Use of Antidepressive Agents and Bone Mineral Density in Women: A Meta-Analysis.

Authors:  Julietta Ursula Schweiger; Ulrich Schweiger; Michael Hüppe; Kai G Kahl; Wiebke Greggersen; Kamila Jauch-Chara; Eva Fassbinder
Journal:  Int J Environ Res Public Health       Date:  2018-06-30       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.